Displaying drugs 1401 - 1425 of 2774 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Ataluren | 284.242 C15H9FN2O3 | A medication used for the treatment of Duchenne muscular dystrophy. | Musculo-Skeletal System / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / Oxazoles / UGT1A9 Substrates | |
Belinostat | 318.35 C15H14N2O4S | A histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). | Histone deacetylase (HDAC) inhibitors | |
Ingenol mebutate | 430.541 C25H34O6 | A topical agent used for the treatment of actinic keratosis. | Cell Death Inducer | |
Ezogabine | 303.3314 C16H18FN3O2 | An antiepileptic agent used as an adjuvant treatment of partial-onset seizures. | Anticonvulsants / Central Nervous System Depressants | |
Pirfenidone | 185.2218 C12H11NO | An agent used for the treatment of idiopathic pulmonary fibrosis (IPF). | Analgesics / Antineoplastic Agents / Pyridones / Tumor Necrosis Factor Blockers | |
Lofexidine | 259.132 C11H12Cl2N2O | A centrally acting alpha2-adrenergic agonist used for the symptomatic treatment of acute opioid withdrawal syndrome to facilitate abrupt opioid discontinuation in adults. | Drugs Used in Opioid Dependence | |
Iloperidone | 426.4806 C24H27FN2O4 | An atypical antipsychotic agent used to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults. | Agents that produce hypertension / Neurotoxic agents | |
Crofelemer | Not Available | An antidiarrheal agent used for the symptomatic relief of drug-induced non-infectious diarrhea in adult patients with HIV/AIDS receiving antiretroviral therapy. | Antidiarrheals | |
Ospemifene | 378.891 C24H23ClO2 | A non-hormonal estrogen receptor modulator (SERM) used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. | Selective Estrogen Receptor Modulators | |
Afamelanotide | 1646.8452 C78H111N21O19 | An injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP). | Protectives Against UV-Radiation for Systemic Use | |
Permethrin | 391.288 C21H20Cl2O3 | An insecticide used to prevent infestation with Sarcoptes scabiei (scabies). | Pyrethrines, Incl. Synthetic Compounds | |
Clevidipine | 456.316 C21H23Cl2NO6 | A dihydropyridine L-type calcium channel blocker used to lower blood pressure when oral antihypertensive therapy is not feasible or not desirable. | Dihydropyridine Derivatives | |
Ceftobiprole | 534.57 C20H22N8O6S2 | A broad spectrum 5th-generation cephalosporin antibacterial indicated for certain kinds of pneumonia, bacteremia, and skin and skin structure infections, including those caused by MRSA. | Anti-Bacterial Agents | |
Oritavancin | 1793.101 C86H97Cl3N10O26 | An antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria. | Glycopeptide Antibacterials | |
Flibanserin | 390.4021 C20H21F3N4O | A 5-HT receptor modulator used for the treatment of selected premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). | Agents that produce hypertension | |
Ximelagatran | 473.5652 C24H35N5O5 | For the treatment of acute deep vein thrombosis. | Antithrombins | |
Milnacipran | 246.354 C15H22N2O | A selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of fibromyalgia and a short-term treatment of major depressive disorder. | Agents producing tachycardia | |
Bepotastine | 388.888 C21H25ClN2O3 | An ophthalmic H1 antagonist used to treat itchiness associated with allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists | |
Enoximone | 248.301 C12H12N2O2S | A selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure. | Phosphodiesterase Inhibitors | |
Vildagliptin | 303.3993 C17H25N3O2 | A once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. | DPP-IV Inhibitors | |
Lorcaserin | 195.69 C11H14ClN | A serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities. | Centrally Acting Antiobesity Products | |
Nilotinib | 529.5158 C28H22F3N7O | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. | Protein Kinase Inhibitors | |
Omacetaxine mepesuccinate | 545.6213 C29H39NO9 | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. | Antineoplastic Agents | |
Huperzine A | 242.3162 C15H18N2O | Investigated for use/treatment in alzheimer's disease. | Cholinesterase Inhibitors / Neuroprotective Agents | |
Nebivolol | 405.435 C22H25F2NO4 | A beta blocking agent used to treat hypertension and aid in the management of heart failure. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides |
Displaying drugs 1401 - 1425 of 2774 in total